Forte Biosciences Inc FBRX:NASDAQ

RT Quote | USD
Last | 05/20/24 EDT
0.5879UNCH (UNCH)
Volume
24,057
52 week range
0.38 - 1.06
Loading...
  • Open0.60
  • Day High0.629
  • Day Low0.5101
  • Prev Close0.6071
  • 52 Week High1.06
  • 52 Week High Date06/23/23
  • 52 Week Low0.38
  • 52 Week Low Date11/14/23

Key Stats

  • Market Cap21.424M
  • Shares Out36.44M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.20
  • YTD % Change-28.45

KEY STATS

  • Open0.60
  • Day High0.629
  • Day Low0.5101
  • Prev Close0.6071
  • 52 Week High1.06
  • 52 Week High Date06/23/23
  • 52 Week Low0.38
  • 52 Week Low Date11/14/23
  • Market Cap21.424M
  • Shares Out36.44M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.20
  • YTD % Change-28.45

RATIOS/PROFITABILITY

  • EPS (TTM)-1.03
  • P/E (TTM)-0.57
  • Fwd P/E (NTM)-1.01
  • EBITDA (TTM)-33.417M
  • ROE (TTM)-104.30%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-583,266.69%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Forte Biosciences Inc

 

Content From Our Affiliates

Profile

MORE
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases. The Company is advancing its product candidate, FB-102, which is a proprietary molecule with potentially broad autoimmune applications, including in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA). The Company’s FB-102 program focuses on addressing key pathways implicated in these indications with a CD122...
Paul Wagner Ph.D.
Chairman of the Board, Chief Executive Officer
Hubert Chen M.D.
President, Chief Scientific Officer
Antony Riley
Chief Financial Officer
Address
3060 PEGASUS PARK DRIVE, BUILDING 6
Dallas, TX
75247
United States

Top Peers

SYMBOLLASTCHG%CHG
LSTA
Lisata Therapeutics Inc
3.00UNCHUNCH
PYPD
PolyPid Ltd
4.71UNCHUNCH
ITRM
Iterum Therapeutics PLC
1.41UNCHUNCH
VINC
Vincerx Pharma Inc
0.7196UNCHUNCH
SRZN
Surrozen Inc
9.71UNCHUNCH